Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
Breccia
Massimo
M
D'Elia
Gianna Maria
GM
D'Andrea
Mariella
M
Latagliata
Roberto
R
Alimena
Giuliana
G
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000139:chemically induced* / Q000209:etiology; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D010996:Pleural Effusion / Q000139:chemically induced* / Q000209:etiology; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate